APP and Alzheimer disease: Because in biAT mice, our bigenic AD model, the amyloid pathology synergistically promotes tau phosphorylation and tauopathy in limbic regions by activating GSK3 [24], we analyzed AAV-APP.SLA mice for endogenous mouse tau phosphorylation.